Found: 6
Select item for more details and to access through your institution.
Fatigue: an overlooked determinant of physical function in scleroderma.
- Published in:
- Rheumatology, 2009, v. 48, n. 2, p. 165
- By:
- Publication type:
- Article
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Systemic and secretory antibody response of atopic and non-atopic individuals to intranasally administered tetanus toxoid.
- Published in:
- Clinical & Experimental Allergy, 1973, v. 3, n. 1, p. 43, doi. 10.1111/j.1365-2222.1973.tb01308.x
- By:
- Publication type:
- Article